Regulatory mechanism of ZNF139 in multi-drug resistance of gastric cancer cells

[1]  M. Dong,et al.  Down regulation of CAII is associated with tumor differentiation and poor prognosis in patients with pancreatic cancer , 2013, Journal of surgical oncology.

[2]  Yong Li,et al.  Tumor chemosensitivity is correlated with expression of multidrug resistance associated factors in variously differentiated gastric carcinoma tissues. , 2012, Hepato-gastroenterology.

[3]  Hui Zhao,et al.  Clusterin confers resistance to TNF-alpha-induced apoptosis in breast cancer cells through NF-kappaB activation and Bcl-2 overexpression , 2012, Journal of chemotherapy.

[4]  C. Dass,et al.  Role of Bcl‐2 in tumour cell survival and implications for pharmacotherapy , 2012, The Journal of pharmacy and pharmacology.

[5]  J. Kim,et al.  Carnitine sensitizes TRAIL-resistant cancer cells to TRAIL-induced apoptotic cell death through the up-regulation of Bax. , 2012, Biochemical and biophysical research communications.

[6]  J. Yun,et al.  High-expression of ZBP-89 correlates with distal metastasis and poor prognosis of patients in clear cell renal cell carcinoma. , 2012, Biochemical and biophysical research communications.

[7]  I. Arisi,et al.  LMNA Knock-Down Affects Differentiation and Progression of Human Neuroblastoma Cells , 2012, PloS one.

[8]  J. Usuda,et al.  Pathological Vascular Invasion and Tumor Differentiation Predict Cancer Recurrence in Stage ia Non–Small-Cell Lung Cancer After Complete Surgical Resection , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[9]  Yong Li,et al.  Heterogeneity of COX-2 and multidrug resistance between primary tumors and regional lymph node metastases of gastric cancer. , 2012, Tumori.

[10]  Xiaoming Lu,et al.  Special AT-rich sequence binding protein 1 regulates the multidrug resistance and invasion of human gastric cancer cells. , 2012, Oncology letters.

[11]  Ke-feng Lei,et al.  Prognostic value of nuclear maspin expression for adjuvant 5-fluorouracil-based chemotherapy in advanced gastric cancer. , 2012, Experimental and therapeutic medicine.

[12]  Wen He,et al.  Down Regulation of CIAPIN1 Reverses Multidrug Resistance in Human Breast Cancer Cells by Inhibiting MDR1 , 2012, Molecules.

[13]  R. Malekzadeh,et al.  The Insulin Receptor Substrate 1 (Irs1) in Intestinal Epithelial Differentiation and in Colorectal Cancer , 2012, PloS one.

[14]  J. Dou,et al.  Downregulation of gene MDR1 by shRNA to reverse multidrug-resistance of ovarian cancer A2780 cells. , 2012, Journal of cancer research and therapeutics.

[15]  X. Zou,et al.  Inhibition of activated Stat3 reverses drug resistance to chemotherapeutic agents in gastric cancer cells. , 2012, Cancer letters.

[16]  J. Christensen,et al.  MET Activation Mediates Resistance to Lapatinib Inhibition of HER2-Amplified Gastric Cancer Cells , 2012, Molecular Cancer Therapeutics.

[17]  Y. Shu,et al.  Paeoniflorin modulates multidrug resistance of a human gastric cancer cell line via the inhibition of NF-κB activation. , 2011, Molecular medicine reports.

[18]  D. Baskić,et al.  Neuroendocrine differentiation as an indicator of chemosensitivity and prognosis in nonsmall cell lung cancer , 2011, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[19]  Jing Zhao,et al.  Promoter polymorphism of MRP1 associated with reduced survival in hepatocellular carcinoma. , 2010, World journal of gastroenterology.

[20]  Guowen Wang,et al.  A novel gene P28GANK confers multidrug resistance by modulating the expression of MDR-1, Bcl-2, and bax in osteosarcoma cells , 2010, Molecular Biology.

[21]  A. Wróbel,et al.  Lignans and norlignans inhibit multidrug resistance protein 1 (MRP1/ABCC1)-mediated transport. , 2010, Anticancer research.

[22]  T. Uchiumi,et al.  [Cisplatin sensitivity transcriptional factor and mitochondrial DNA maintenance protein]. , 2009, Rinsho byori. The Japanese journal of clinical pathology.

[23]  W. Hop,et al.  Array comparative genomic hybridization, expression array, and protein analysis of critical regions on chromosome arms 1q, 7q, and 8p in adenocarcinomas of the gastroesophageal junction. , 2009, Cancer genetics and cytogenetics.

[24]  K. Kalland,et al.  Highly infiltrative brain tumours show reduced chemosensitivity associated with a stem cell‐like phenotype , 2009, Neuropathology and applied neurobiology.

[25]  M. Idrees,et al.  In Vitro Chemoresistance Testing in Well-Differentiated Carcinoid Tumors , 2009, Annals of Surgical Oncology.

[26]  Katsuyuki Tozawa,et al.  Oxaliplatin in treatment of the cisplatin-resistant MKN45 cell line of gastric cancer. , 2008, Anticancer research.

[27]  Jun Zhou,et al.  Silencing of ZNF217 gene influences the biological behavior of a human ovarian cancer cell line. , 2008, International journal of oncology.

[28]  D. Erdmann,et al.  Modulation of drug resistance by artificial transcription factors , 2008, Molecular Cancer Therapeutics.

[29]  Albert D Donnenberg,et al.  Tumorigenic stem and progenitor cells: implications for the therapeutic index of anti-cancer agents. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[30]  N. Tommerup,et al.  Isolation and fine mapping of 16 novel human zinc finger-encoding cDNAs identify putative candidate genes for developmental and malignant disorders. , 1995, Genomics.